APPENDICES - NIHR Health Technology Assessment Programme

DOI: 10.3310/hta14370 Health Technology Assessment 2010; Vol. 14: No. 37
for early Barrett’s-associated esophageal cancer.
Gastroenterology 2003;124:A298.
38. Jamieson NF, Thorpe S, Masse A, Bown SG, Lovat
LB. Photodynamic therapy using mTHPC for
early Barrett’s-associated oesophageal cancers. Gut
2003;52:170.
39. Javaid B, Watt P, Krasner N. Photodynamic
therapy (PDT) for oesophageal dysplasia and early
carcinoma with mTHPC (m-tetrahydroxyphenyl
chlorin): a preliminary study. Lasers Med Sci
2002;17:51–6.
40. Javaid B, Watt P, Krasner N, Brouwer PA.
Oesophageal photodynamic therapy with mTHPC
(m-tetra hydroxyphenyl chlorin) using a laser
and a non-laser light source: a pilot study. SPIE
Proceedings Series 2001;4156:262–5.
41. Jenkins JT, Charles A, Mitchell KG, Fullarton
GM. Photodynamic therapy for Barretts’
adenocarcinoma associated with an Angelchik
device. Photodiag Photodyn Ther 2005;2:197–200.
42. Kashtan H, Umansky M, Birkenfeld S, Scherubl
H, Haddad R, Greenberg R, et al. Photodynamic
therapy of Barrett’s esophagus with dysplasia
using systemic aminolevulinic acid and a non-laser
light source. A phase I/II study. Gastrointest Oncol
2002;4:153–7.
43. Kashtan H, Umansky M, Birkenfeld S, Scherubl
H, Haddad R, Greenberg R, et al. Photodynamic
therapy of Barrett’s esophagus with dysplasia
using systemic aminolevulinic acid and a non-laser
light source. A phase I/II study. Gastrointest Oncol
2002;4:153–8.
44. Keeley SB, Luketich JD, Landreneau RJ, Christie
NA, Rivera MA, McGrath K. Using photodynamic
therapy to cure esophageal cancer and Barrett’s
high-grade dysplasia. Ann Surg Oncol 2006;13:85.
45. Keeley SB, Pennathur A, Gooding W, Landreneau
RJ, Christie NA, Luketich J. Photodynamic therapy
with curative intent for Barrett’s esophagus with
high grade dysplasia and superficial esophageal
cancer. Ann Surg Oncol 2007;14:2406–10.
46. Krishna M, Nakhleh RE, Hemminger LL, Wolfsen
HC. Histologic characteristics and follow-up of
37 cases of Barrett’s esophagus with high grade
dysplasia and intramucosal adenocarcinoma treated
with photodynamic therapy. Lab Invest 2006;86:504.
47. Krishna M, Nakhleh RE, Hemminger LL, Wolfsen
HC. Histologic characteristics and follow-up of
37 cases of Barrett’s esophagus with high grade
dysplasia and intramucosal adenocarcinoma
treated with photodynamic therapy. Mod Pathol
2006;19:504.
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
48. Krishnadath KK, Wang KK, Taniguchi K, Sebo
TJ, Buttar NS, Anderson MA, et al. Persistent
genetic abnormalities in Barrett’s esophagus
after photodynamic therapy. Gastroenterology
2000;119:624–30.
49. Laukka MA, Wang KK. Initial results using low-dose
photodynamic therapy in the treatment of Barrett’s
esophagus. Gastrointest Endosc 1995;42:59–63.
50. Lovat LB, Jamieson NF, Novelli MR, Mosse CA,
Selvasekar C, Mackenzie GD, et al. Photodynamic
therapy with m-tetrahydroxyphenyl chlorin for
high-grade dysplasia and early cancer in Barrett’s
columnar lined esophagus. Gastrointest Endosc
2005;62:617–23.
51. Luketich JD, Fernando HC, Christie NA, Litle VR,
Ferson PF, Buenaventura PO, et al. Photodynamic
therapy in thoracic oncology: a single institution
experience. SPIE Proceedings Series 2001;4248:28–
33.
52. Macrae FA, Rajesekaram R, Thomas R, Bhathal PS.
Photodynamic therapy in high grade dysplasia in
Barrett’s oesophagus using 5 amino-laevulinic acid
sensitization. Gastrointest Endosc 2004;59:A252.
53. Mino-Kenudosn M, Ban S, Deshpande V, Shimizu
M, Lauwers GY. Buried dysplasia and early
adenocarcinoma arising in Barrett esophagus (BE)
after photodynamic therapy (PDT): not uncommon
findings. Mod Pathol 2006;19:516.
54. Mino-Kenudson M, Ban S, Deshpande V, Shimizu
M, Lauwers GY. Buried dysplasia and early
adenocarcinoma arising in Barrett Esophagus (BE)
after photodynamic therapy (PDT): not uncommon
findings. Lab Invest 2006;86:114A.
55. Mino-Kenudson M, Ban S, Ohana M, Puricelli W,
Deshpande V, Shimizu M, et al. Buried dysplasia and
early adenocarcinoma arising in Barrett esophagus
after porfimer-photodynamic therapy. Am J Surg
Pathol 2007;31:403–9.
56. Mino-Kenudson M, Lauwers GY. Pathology of
Barrett esophagus after photodynamic therapy. Mod
Pathol 2007;20:550.
57. Moghissi K, Dixon K. The role of photodynamic
therapy (PDT) in pre-malignant and malignant
oesophageal lesions: can PDT compete with
surgery? Laser Helsinki 2008, 13th International
Congress of EMLA (European Medical Laser
Association) in conjunction with EMLA Finland
and MAL (Medical Acupuncture and Laser) in
cooperation with ASLMS (American Society for
Laser Medicine and Surgery), Helsinki, 2008.
58. Moghissi K, Dixon K, Thorpe JAC, Stringer
MR. The role of photodynamic therapy (PDT)
153